SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001570562-23-000119
Filing Date
2023-12-20
Accepted
2023-12-20 08:33:22
Documents
14
Period of Report
2023-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eols-20231220.htm   iXBRL 8-K 30509
2 EX-99.1 form8k12202023ex991.htm EX-99.1 41449
6 imagea.jpg GRAPHIC 10269
  Complete submission text file 0001570562-23-000119.txt   228396

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20231220.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20231220_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20231220_pre.xml EX-101.PRE 13053
8 EXTRACTED XBRL INSTANCE DOCUMENT eols-20231220_htm.xml XML 3101
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 231499453
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)